Alexander Levitzki
Director/Board Member en The Institute for Advanced Studies In Aging & Geriatric Medi .
Perfil
Alexander Levitzki is the founder of TK-Signal Ltd.
(founded in 2001) and NovoTyr Therapeutics Ltd.
(founded in 2005).
He held the title of Chief Scientific Officer at TK-Signal Ltd.
and Director & Chief Scientific Officer at NovoTyr Therapeutics Ltd.
Dr. Levitzki is currently the Director at The Institute for Advanced Studies In Aging & Geriatric Medi, Director at Targimmune Therapeutics AG, Professor at The Hebrew University of Jerusalem (since 1977), and Member at Israel Academy of Sciences & Humanities.
He previously held the position of Director at BioCancell Therapeutics, Inc. and Director at Quinova Rx Ltd.
Cargos activos de Alexander Levitzki
Empresas | Cargo | Inicio |
---|---|---|
The Hebrew University of Jerusalem | Corporate Officer/Principal | 01/01/1977 |
The Institute for Advanced Studies In Aging & Geriatric Medi | Director/Board Member | - |
Israel Academy of Sciences & Humanities
Israel Academy of Sciences & Humanities Miscellaneous Commercial ServicesCommercial Services The Israel Academy of Sciences & Humanities is the national academy of science in Israel. The private company is based in Jerusalem, Israel. The academy sees the promotion and developer of the basic scientific research system of a target of national importance. Founded in 1961, its aim is to concentrate on the best of personal science residents, nurturing and promoting scientific activity, advising the government on research and scientific planning of national importance, having contact with parallel bodies outside-to represent Israeli science in institutions and in international conferences and publish reporters to promote science. | Corporate Officer/Principal | - |
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Director/Board Member | - |
Antiguos cargos conocidos de Alexander Levitzki.
Empresas | Cargo | Fin |
---|---|---|
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Director/Board Member | 15/11/2009 |
TK-Signal Ltd.
TK-Signal Ltd. Medical SpecialtiesHealth Technology TK-Signal Ltd. develops therapies for hematological cancer applications. Its product TKS040, which manage and trace focused drug therapy for cancer patients. The firm also develops various radiopharmaceutical molecular imaging tracers, specific molecular radiotherapy agents, and radioactive biomarkers to diagnose and monitor cancerous tumors. TK-Signal was founded in 2001 by Eyal Mishani and Alexander Levitzki and is headquartered in Jerusalem, Israel. | Founder | - |
NovoTyr Therapeutics Ltd.
NovoTyr Therapeutics Ltd. Medical SpecialtiesHealth Technology NovoTyr Therapeutics Ltd. develops insulin-like growth factor receptor inhibitors. It provides services in the biotechnology, drug development, cancer and other proliferative disease sectors. The company was founded by Alexander Levitzki in 2005 and is headquartered in Kiryat Shmona, Israel | Founder | - |
Quinova Rx Ltd.
Quinova Rx Ltd. Pharmaceuticals: MajorHealth Technology Quinova Rx Ltd. develops cannabinoid quinone scaffold for antineoplastic therapy. The company was founded by Natalya Kogan in May 2007 and is headquartered in Kiryat Shmona, Israel. | Director/Board Member | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 7 |
---|---|
The Institute for Advanced Studies In Aging & Geriatric Medi | |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
TK-Signal Ltd.
TK-Signal Ltd. Medical SpecialtiesHealth Technology TK-Signal Ltd. develops therapies for hematological cancer applications. Its product TKS040, which manage and trace focused drug therapy for cancer patients. The firm also develops various radiopharmaceutical molecular imaging tracers, specific molecular radiotherapy agents, and radioactive biomarkers to diagnose and monitor cancerous tumors. TK-Signal was founded in 2001 by Eyal Mishani and Alexander Levitzki and is headquartered in Jerusalem, Israel. | Health Technology |
NovoTyr Therapeutics Ltd.
NovoTyr Therapeutics Ltd. Medical SpecialtiesHealth Technology NovoTyr Therapeutics Ltd. develops insulin-like growth factor receptor inhibitors. It provides services in the biotechnology, drug development, cancer and other proliferative disease sectors. The company was founded by Alexander Levitzki in 2005 and is headquartered in Kiryat Shmona, Israel | Health Technology |
Quinova Rx Ltd.
Quinova Rx Ltd. Pharmaceuticals: MajorHealth Technology Quinova Rx Ltd. develops cannabinoid quinone scaffold for antineoplastic therapy. The company was founded by Natalya Kogan in May 2007 and is headquartered in Kiryat Shmona, Israel. | Health Technology |
Israel Academy of Sciences & Humanities
Israel Academy of Sciences & Humanities Miscellaneous Commercial ServicesCommercial Services The Israel Academy of Sciences & Humanities is the national academy of science in Israel. The private company is based in Jerusalem, Israel. The academy sees the promotion and developer of the basic scientific research system of a target of national importance. Founded in 1961, its aim is to concentrate on the best of personal science residents, nurturing and promoting scientific activity, advising the government on research and scientific planning of national importance, having contact with parallel bodies outside-to represent Israeli science in institutions and in international conferences and publish reporters to promote science. | Commercial Services |
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Alexander Levitzki